Skip to content
  • Sponsors
  • Sponsorship Opportunities
  • The Connecticut Health I-Team
  • Contact
Donate Now
  • Donate Now
  • C-HIT
  • C-HIT
  • Veterans’ Health
  • Environmental Health
  • Women’s Health
  • Disparities
  • Fines & Sanctions
  • Donate Now
  • Global Navigation
    • Sponsors
    • Sponsorship Opportunities
    • The Connecticut Health I-Team
    • Contact

Connecticut Health Investigative Team - In-depth Journalism on Issues of Health and Safety

Connecticut Health Investigative Team (http://c-hit.org/tag/ronald-duman/)

  • Veterans’ Health
  • Environmental Health
  • Women’s Health
  • Disparities
  • Fines & Sanctions
  • I-Team In-Depth
  • News Ticker
  • Data Mine
  • Students’ Work
  • Podcast
  • Health Q&A
Subscribe

Ronald Duman

Chronic Depression

After SSRIs: Yale Scientists Map New Pathway To Treat Depression

By Lisa Chedekel | October 4, 2012

For a decade, scientists have been trying to explain why a single dose of the drug ketamine manages to do what typical antidepressants don’t: Lift symptoms of chronic depression within hours, rather than weeks, in treatment-resistant patients.

  • Connecticut Health I-Team
  • The Connecticut Health I-Team
  • Sponsors
  • Contributors
  • Contact

In Case You Missed It

  • For Some Transgender People, Pandemic Paves Path To Transition

    Kyle Avery Jones had recently come out as transgender to her parents and friends when her final semester at the University of Connecticut began in January 2020.

  • Low-Income Children Are Most Vulnerable To Pandemic’s Long-Term Effects

    Tameeka Coleman and six of her children lived on the streets before moving into a shelter in Fairfield.

Follow Us

Like Us on FacebookFollow Us on TwitterFollow Us on InstagramSubscribe via RSS

© Copyright 2021, Connecticut Health I-Team

  • Site Policies

Built with the Largo WordPress Theme from the Institute for Nonprofit News.

Back to top ↑